Location; Slough (Hybrid – 2 days office, 3 days home) We are working with a fast-growing B2B SaaS business operating within the parts and inventory management sector, serving major names in food manufacturing and automotive engineering.
Interim Education Place Planning Officer West Berkshire (Hybrid Working) 18.5 hours per week £30 per hour (Umbrella) An exciting opportunity has arisen for an experienced Education Place Planning Officer to join a busy Place Planning team
This is a self-funded programme that leads to employment, fees apply. Job Guarantee Complete the programme and get a job, or get your course fees back. Looking to start a career in Software Development? We are offering
Design Manager - Berkshire (Hybrid) Were working with a well-established national contractor with an excellent reputation for delivering a variety of high-quality projects. They are looking to appoint an experienced Design Manager to lead and coordinate the
New Homes Sales Executive Bracknell and surrounding developments Up to £38,500 depending on experience 12-month fixed-term contract Tuesday to Saturday, 9am–5pm | 37 hours per week Some sales jobs are about shifting products. This one is
This is a self-funded programme that leads to employment, fees apply. Job Guarantee Complete the programme and get a job, or get your course fees back. Looking to start a career in Software Development? We are offering
Information Technology Service Delivery Manager IT Service Delivery Manager Location: Watford (Hybrid 3 days office based and 2 days working from home) Salary: Competitive + Benefits Closing date: 31st July 2026 About Us At Corona Energy,
Interim Education Place Planning Officer West Berkshire (Hybrid Working) 18.5 hours per week £30 per hour (Umbrella) An exciting opportunity has arisen for an experienced Education Place Planning Officer to join a busy Place Planning team
Manager, Quality Systems - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transformative medicines which address unmet patient needs in